These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34377502)

  • 1. The BC ADPKD Network: A Comprehensive Provincial Approach to Support Specialized and Locally Delivered Multidisciplinary ADPKD Care.
    Bevilacqua M; Gradin S; Williams J; Romann A; Lo C; Djurdjev O; Levin A
    Can J Kidney Health Dis; 2021; 8():20543581211035218. PubMed ID: 34377502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical Care Network in the State of Qatar.
    Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF
    Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An overview of the British Columbia Glomerulonephritis network and registry: integrating knowledge generation and translation within a single framework.
    Barbour S; Beaulieu M; Gill J; Djurdjev O; Reich H; Levin A
    BMC Nephrol; 2013 Oct; 14():236. PubMed ID: 24168011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protocol for a Multistage Mixed-Methods Evaluation of Multidisciplinary Chronic Kidney Disease Care Quality Following Integration of Virtual and In-Person Care During the COVID-19 Pandemic.
    Bevilacqua M; Chiu H; Melnyk Y; Williams J; Chohan R; Wei J; Stoll D; Fryer M; McGuire M; Logie A; Watson P; Levin A
    Can J Kidney Health Dis; 2022; 9():20543581221103103. PubMed ID: 35676893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Provincial Survey of the Contemporary Management of Autosomal Dominant Polycystic Kidney Disease.
    Yi TW; Levin A; Bevilacqua M; Canney M
    Can J Kidney Health Dis; 2020; 7():2054358120948294. PubMed ID: 32953126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The BC Glomerulonephritis Network: Improving Access and Reducing the Cost of Immunosuppressive Treatments for Glomerular Diseases.
    Barbour S; Lo C; Espino-Hernandez G; Gill J; Levin A
    Can J Kidney Health Dis; 2018; 5():2054358118759551. PubMed ID: 29581884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidney Check Point-of-Care Testing-Furthering Patient Engagement and Patient-Centered Care in Canada's Rural and Remote Indigenous Communities: Program Report.
    Curtis S; Martin H; DiNella M; Lavallee B; Chartrand C; McLeod L; Woods C; Dart A; Tangri N; Rigatto C; Komenda P
    Can J Kidney Health Dis; 2021; 8():20543581211003744. PubMed ID: 33868690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European ADPKD Forum multidisciplinary position statement on autosomal dominant polycystic kidney disease care: European ADPKD Forum and Multispecialist Roundtable participants.
    ; Harris T; Sandford R; ;
    Nephrol Dial Transplant; 2018 Apr; 33(4):563-573. PubMed ID: 29309655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan.
    Arai H; Ouchi Y; Toba K; Endo T; Shimokado K; Tsubota K; Matsuo S; Mori H; Yumura W; Yokode M; Rakugi H; Ohshima S
    Geriatr Gerontol Int; 2015 Jun; 15(6):673-87. PubMed ID: 25656311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inaugural Qatar Critical Care Conference with its Qatar Medical Journal Special Issue - An important milestone.
    Hassan IF; Alinier G
    Qatar Med J; 2019; 2019(2):1. PubMed ID: 31763204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility and outcomes of paid undergraduate student nurse positions.
    Gamroth L; Budgen C; Lougheed M
    Nurs Leadersh (Tor Ont); 2006 Sep; 19(3):e1-14. PubMed ID: 19830923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Building a network of ADPKD reference centres across Europe: the EuroCYST initiative.
    Petzold K; Gansevoort RT; Ong AC; Devuyst O; Rotar L; Eckardt KU; Köttgen A; Pirson Y; Remuzzi G; Sandford R; Tesar V; Ecder T; Chaveau D; Torra R; Budde K; Le Meur Y; Wüthrich RP; Serra AL
    Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4():iv26-32. PubMed ID: 25165183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A model to predict disease progression in patients with autosomal dominant polycystic kidney disease (ADPKD): the ADPKD Outcomes Model.
    McEwan P; Bennett Wilton H; Ong ACM; Ørskov B; Sandford R; Scolari F; Cabrera MV; Walz G; O'Reilly K; Robinson P
    BMC Nephrol; 2018 Feb; 19(1):37. PubMed ID: 29439650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ESRD from autosomal dominant polycystic kidney disease in the United States, 2001-2010.
    Reule S; Sexton DJ; Solid CA; Chen SC; Collins AJ; Foley RN
    Am J Kidney Dis; 2014 Oct; 64(4):592-9. PubMed ID: 25134777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Starting Dialysis on Time, At Home on the Right Therapy (START): Description of an Intervention to Increase the Safe and Effective Use of Peritoneal Dialysis.
    Quinn RR; Mohamed F; Pauly R; Schwartz T; Scott-Douglas N; Morrin L; Kozinski A; Manns BJ; Klarenbach S; Clarke A; Fox DE; Oliver MJ
    Can J Kidney Health Dis; 2021; 8():20543581211003764. PubMed ID: 33868692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoting and supporting self-management for adults living in the community with physical chronic illness: A systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter.
    Rees S; Williams A
    JBI Libr Syst Rev; 2009; 7(13):492-582. PubMed ID: 27819974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling the long-term benefits of tolvaptan therapy on renal function decline in autosomal dominant polycystic kidney disease: an exploratory analysis using the ADPKD outcomes model.
    Bennett H; McEwan P; Hamilton K; O'Reilly K
    BMC Nephrol; 2019 Apr; 20(1):136. PubMed ID: 31014270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Area Data Standards for Autosomal Dominant Polycystic Kidney Disease: A Report From the Polycystic Kidney Disease Outcomes Consortium (PKDOC).
    Perrone RD; Neville J; Chapman AB; Gitomer BY; Miskulin DC; Torres VE; Czerwiec FS; Dennis E; Kisler B; Kopko S; Krasa HB; LeRoy E; Castedo J; Schrier RW; Broadbent S
    Am J Kidney Dis; 2015 Oct; 66(4):583-90. PubMed ID: 26088508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAPID-ADPKD (Retrospective epidemiological study of Asia-Pacific patients with rapId Disease progression of Autosomal Dominant Polycystic Kidney Disease): study protocol for a multinational, retrospective cohort study.
    Ryu H; Park HC; Oh YK; Sangadi I; Wong A; Mei C; Ecder T; Wang AY; Kao TW; Huang JW; Rangan GK; Ahn C
    BMJ Open; 2020 Feb; 10(2):e034103. PubMed ID: 32034027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.